A Historic Agreement to Enhance Cancer Treatment in Egypt
In a pivotal moment, an unprecedented agreement was signed between the Egyptian Cancer Society and the American Society of Clinical Oncology (ASCO) with the aim of radically transforming the cancer treatment system in Egypt and enabling Egyptian physicians to access the latest global protocols.
The agreement was signed during the ASCO Annual Meeting 2025, in the presence of leaders from both sides, including:
* Prof. Dr. Hesham El-Ghazaly – President of the Egyptian Cancer Society
* Dr. Ola Khorshid – Board Member
* Dr. Cliff Hodes – CEO of the American Society of Clinical Oncology
* Dr. Robin Zonn – President of the Society
* Dr. Eric Small – President-Elect of ASCO
The agreement was described as a historic leap forward and the first of its kind in Egypt, the Arab world, and Africa, aiming to:
✅ Train Egyptian medical personnel
✅ Localize international diagnostic and treatment protocols
✅ Support collaborative research
✅ Provide updated and continuous educational platforms
The agreement comes at a time when there is a growing need for advanced scientific responses to address rising cancer rates and establish equity in healthcare.
This new partnership paves the way for Egypt to become a regional hub for training and treatment, serving patients within the country and across the Middle East and Africa.
This step confirms that the future of cancer care in Egypt begins now, here.
